NFKB1 and metabolic dysfunction-associated steatohepatitis: In NASH, the inflammatory response is predominantly mediated by the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) contributing to steatohepatitis progression into severe forms of liver injury such as cirrhosis, fibrosis, and HCC [48].